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Abstract
Macrophages are recognized cellular compartments involved in HIV infection; however, the extent to which precursor monocytes are infected
in vivo and its significance remains poorly understood. Our aim was to analyze the contribution of monocytes to HIV infection in vivo. PCR assays
did not detect HIV-1 proviral DNA in monocytes of HAART-suppressed patients. Monocyte-derived macrophages from individuals under
suppressive HAART did not show evidence of harboring HIV, thereby, minimizing the possibility of infection by the integration of sequestered
virus after differentiation. These results suggest that the infection of permissive monocytes is directly related to the success of HAART (pb0.001).
HIV-1 env was characterized from patients under sub-optimal HAART and hence, with infected monocytes. Sequence analyses showed a
consistent relationship between monocytes and plasma virus. Altogether, we found that in suppressive HAART, neither monocytes nor
Monocyte-derived macrophages-harbored HIV.
© 2007 Elsevier Inc. All rights reserved.Keywords: HIV-1; Suppressive HAART; HAART; Monocytes; Macrophages; MDM; Dendritic cellsIntroduction
In the last 18 years, research in monocyte virology has
yielded conflicting results. Two lines of thinking, one that
suggests the importance of monocytes as virus reservoir and
another that ascribes minimal importance of monocytes in HIV
persistence, are based on discordant in vivo and in vitro data
regarding the infection of circulating monocytes.
It is known that monocytes belong to a family of mono-
nuclear phagocytic cells derived from hematopoietic stem cells
in the bone marrow, circulate in the bloodstream for 5–7 days,
and differentiate into macrophages, a highly specialized and
phenotypically variable cell population (Crowe et al., 2003;⁎ Corresponding author. Fax: +787 843 0221.
E-mail address: elorenzo@psm.edu (E. Lorenzo).
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doi:10.1016/j.virol.2007.07.010Noursadeghi et al., 2006; van Furth and Cohn, 1968). In
general, cells of the monocyte lineage are considered to be
among the first leukocytes to be infected with HIV and the
second most important virus reservoir.
Early studies reported the lack of virus in monocytes of most
patients and minimized monocytes as endogenous sources of
HIV (McElrath et al., 1989). Apparently, the spontaneous
expression of HIV is not achieved in monocytes in vitro and
differentiation into cells with mature phenotypes renders the
cells susceptible to HIV-infection. After several days in culture,
progressive susceptibility of monocytes to HIV infection was
shown after differentiation into monocyte-derived macrophages
(MDM) (Schuitemaker et al., 1992; Rich et al., 1992). In vivo,
monocytes positive for HIV have been correlated with low CD4
T cell counts (Innocenti et al., 1992). A possible mechanism by
which HIV disseminates in tissues was proposed when
monocytes/macrophages produced HIV upon T-cell-mediated
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monocytes for N1 day allowed for HIV integration and reverse
transcription (RT) (Sonza et al., 1996). These findings raised the
question of whether peripheral blood monocytes are indeed
infected in vivo and at that time, this group concluded that
analyses of monocyte compartment alone will not provide
insights into HIV pathogenesis. Wang et al. (1998) demon-
strated b1% CCR5 expression in freshly isolated monocytes
and, independently of Tuttle et al. (1998), proposed this as a
possible explanation for the absence of infected monocytes in
patients and monocytes' resistance to infection in vitro, since in
these studies, monocytes became infectable after 48 h in culture.
Also, twin studies suggested host factor-mediated inhibition of
HIV replication in monocytes at the level of pre-RT and
independent of CCR5 expression (Naif et al., 1999). Adding
contrast, Neil and co-workers reported the nuclear translocation
as the step that was inhibited in monocytes/macrophages by
using pseudotyped HIV-1 vectors (Neil et al., 2001) but
afterwards, differentiation-dependent cellular factors important
for RT were suggested to be important in monocytes (Triques
and Stevenson, 2004). Altogether, these findings suggest that
host cellular factors, intrinsic to monocytes, may impose
restrictions to HIV infection.
When determining the contribution of MDM to plasma
viremia, Kazanjian and colleagues did not detect virus in
patients treated with protease inhibitors, despite the fact thatTable 1
General clinical information of HIV-1 study subjects
Subject Visits Viral load in plasma a
(copies/ml)
CD4 T ce
(cells/μl)
SH-1 08/13/03 b50 605
SH-2 08/14/03 b50 1356
SH-3 08/14/03 b50 1115
SH-4 08/21/03 b50 518
SH-5 09/29/03 b50 913
SH-6 10/27/03 b50 729
SH-7 11/25/03 b50 1189
02/03/04 166 1363
SH-8 12/17/03 b50 1013
SH-14 01/21/04 b50 1679
SH-30 03/31/05 b50 524
SH-32 04/12/05 15,180 218
SH-34 04/21/05 b50 770
SH-36 05/26/05 4,035 252
SH-37 12/09/03 b50 305
N-1 11/17/05 1210 532
HF-1 01/13/04 8496 566
05/12/04 18,202 551
HF-2 01/15/04 21,942 215
04/02/04 11,250 152
TI-1 08/21/03 852 1006
09/18/03 5299 879
10/09/03 b50 1072
10/30/03 75 795
TI-2 07/07/03 105,763 245
09/22/03 b50 259
NRTI, nucleotide/nucleoside reverse transcriptase inhibitors; NNRTI, non-nucleosid
ritonavir; 3TC, lamivudine; AZT, zidovudine; EFV, efivarenz, d4T, stavudine; LPV, l
atazanavir.
a Viral loads determined by ultrasensitive Amplicor HIV-1 Monitor test (Roche Mmonocytes were isolated after 7 days of adherence in vitro
(Kazanjian et al., 2002). During the same year, the efficacy of
HAART was associated with a low number of infected
circulating monocytes in a cohort of 52 study subjects. In this
study, monocytes were isolated after overnight culture using
activated PBMC and viral replication was assessed in MDM.
This group found that 50% of patients with active viral
replication and b10% of individuals in effective HAART-
harbored infected monocytes. These results led to the proposal
that increased number of circulating infected monocytes
trafficking into CNS precedes high levels of viral replication
and favors the development of encephalitis.
The current view of monocytes as underestimated HIV-1
viral reservoirs even during apparently complete viral suppres-
sion arose from another series of studies. Despite the fact that
b1% of peripheral blood monocytes are infected with HIV-1 in
vivo, the presence of HIV-1 DNA in monocytes has been
confirmed by PCR. In addition, replication-competent virus
have been recovered from monocytes (Sonza et al., 2001). This
group has reported active viral replication in monocytes. While
these authors have indicated that fewer monocytes than resting
T cells are infected in HAART patients, their conclusions did
support that monocytes constitute a continuing source of
infectious HIV in patients regardless of the length of HAART
regimens. Moreover, persistent HIV infection was found in
monocytes, with more frequent renewal of viral forms inll counts Antiretroviral drug regimen
NRTI NNRTI PI
d4T, ddI NFV
d4T, ABC NFV
d4T, 3TC NFV
TDF, 3TC LPV, RTV
d4T, 3TC EFV
3TC, AZT NFV
3TC, AZT NFV
3TC, AZT NFV
ddI, d4T NFV
3TC, AZT IDV
ABC, 3TC ATV
3TC, AZT NFV
3TC, d4T
ABC, 3TC
d4T, 3TC NFV
None None None
d4T EFV LPV, RTV
d4T EFV LPV, RTV
ABC, AZT, 3TC
ABC, AZT, 3TC
None None None
None None None
None None None
None None None
None None None
3TC, d4T NFV
e reverse transcriptase inhibitors; PI, protease inhibitors. IDV, indinavir; RTV,
opinavir; TDF, tenofovir; ABC, abacavir; NFV, nelfinavir; ddI, didanosine; ATV,
olecular Systems, detection limit, 50 copies/ml).
Fig. 1. Virologic and immunological profile of Patient TI-1 during antiretroviral
treatment interruption. HIV-1 plasma viremia (viral load, logarithmically scaled)
and CD4+ T cell counts are shown for visits during HAART interruption or drug
holidays. Arrows show time points analyzed for this study. Note the significant
decline of plasma viremia on time 4 and the rebounding viremia thereafter.
37S. Almodóvar et al. / Virology 369 (2007) 35–46monocytes than in resting CD4+ T cells. This renewal was
ascribed to active viral replication (Zhu, 2000; Zhu et al.,
2002). Therefore, it is believed that blood monocytes are
actively replenishing distant tissues acting as Trojan horses,
especially during the HIV replication that occurs below the
limits of detection in the presence of HAART. In light of the
potential of macrophages to migrate to tissues and establish
new reservoirs for HIV-1 (Nottet et al., 1996; Persidsky et al.,
1999, 1997), many research efforts have been aimed to
determine the role of blood monocytes in different HIV-1
scenarios. Such investigations have included the role of blood
monocytes in residual HIV replication, antiretroviral drug
resistance, and virus reentry into tissues (reseeding).
The discrepancy among several reports calls for the need of
a deeper understanding of the role of monocytes in HIV
infection. Macrophages are well-documented cellular compart-
ments that can be found invariably infected with HIV. How-
ever, the extent to which precursor monocytes are infected in
vivo is still undecided. Considering the significant amount of
evidence suggesting minimal infection of monocytes in vivo,
we derived the rationale that uninfected monocytes as
precursors of tissue macrophages may have a minimal
potential for the replenishment of tissues and other blood
cells with HIV. Specifically, we sought to analyze the proviral
HIV DNA in monocytes to assess the overall contribution of
monocytes to HIV infection in two different scenarios: one
under suppressive HAART, the other with HAART interrup-
tion and failure.
Results
Samples from a total of 19 chronically infected HIV+
patients were analyzed. Table 1 shows relevant clinical
information of the study subjects. Patients with known history
of strong adherence to the prescribed antiretroviral therapy and
stable suppression of plasma viremia (b400 copies/ml) during
≥6 months before and 9–12 months after blood sampling were
included in the “Suppressive HAART” (SH) study group. This
group also included 2 patients (SH-32, and SH-36) with viral
loads N400 copies/ml in the time point of sampling, but
showing continuous decreases in plasma viral loads in the time
points subsequent to sampling and thus, with virologic response
on HAART. One participant of our cohort was naïve for
antiretroviral treatment (N-1), but strongly supplemented with
multi-vitamins. Two participants were included in the group
designated as HAART Failure (named HF-1 and HF-2) based
on reported antiretroviral drug resistance at the time of inclusion
into this study. HF-1 showed mutation Y188L in the RT gene
and L63P at the protease gene; HF-2 showed mutations A62V,
D67N, T69D, K70R, V75I, L100I, K103N, F116Y, Q151M,
T215V, K219Q, and P225H in the RT gene and L63P in the
protease gene. Other participants were undergoing Treatment
Interruption at the time of enrollment (TI-1 and TI-2). Patient
TI-1 was analyzed on 4 time points (Fig. 1); time 3 showed
a period of completely suppression plasma viremia (non-
detectable viral loads by ultrasensitive limits of detection,
HAART-free). Unfortunately, the only specimen available fortime 3 was plasma. Rebounding plasma viremia was evident
in time 4, and viral loads did not decline to baseline levels
on subsequent time points (Fig. 1). Finally, Patient TI-2 was
sampled during antiretroviral treatment interruption (time 1)
and 10 weeks after treatment resumption (time 2).
Blood monocytes and resting CD4+ T cells were purified
from PBMC as described in Materials and methods and
Supplementary material. Primary blood monocytes' suspen-
sions were 95–99% (with ≤1.1% CD3+ cells in the worst case
scenario.) Resting CD4+ T cells' preparations were 96–99 %
pure, based on the expression of cell surface markers assessed
by flow cytometry (Figs. S1–S3).
Amplification of HIV-1 env, nef and tat from genomic DNA
After DNA extractions, nucleic acids were tested spectro-
photometrically and then used for PCR amplification of the
human housekeeping gene β-actin as an internal positive
control. The C2-V4 envelopewas PCR-amplified from genomic
DNA of blood monocytes and resting CD4+ T cells of each
patient. HIV envelope was detected in resting CD4+ T cells, but
not in primary monocytes from 15 of 19 patients, even in
patients sampled more than once. These results were confirmed
by PCR amplifications of HIV-1 nef (full-length) and tat
(exon 1). Based on the clinical information available,
monocytes negative for HIV by PCR analyses were derived
from patients receiving suppressive HAART and patient N-1
(naïve to antiretroviral therapy). HIV-1 env was readily detected
in monocytes of patients with evidence of HAART failure
(HF-1 and HF-2) and those undergoing treatment interrup-
tions (TI-1 and TI-2, time 1). Thus, the detection of infected
primary monocytes correlated with the presence of suboptimal
HAART (pb0.001) and with plasma viremia (pb0.001). These
results indicate that most blood monocytes are not infected with
HIV-1 under the effects of optimal HAART.
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Phylogeny of the envelope gene has been consistently used
to reconstruct the evolutionary history of HIV-1 quasispecies(Hillis et al., 1994; Lorenzo et al., 1996; Ou et al., 1992).
Since the primary goal of this study was to compare HIV
proviral sequences in monocytes and T cells with viral
sequences in plasma, a total of 194 molecular clone sequences
39S. Almodóvar et al. / Virology 369 (2007) 35–46of the HIV-1 C2-V4 envelope region were analyzed from the
four patients with infected monocytes. Phylogenetic analysis
using the NJ methods resulted in monophyletic clusters cor-
responding to each analyzed patient. Clustering was supported
by N70% bootstrap proportions, indicating that laboratory
contamination is unlikely (Fig. S4). Since clinical samples
from the study subjects in earlier time points of infection were
unavailable for this study, we relied in historical sequences of
Puerto Rican HIV-1 env and used it as an outgroup to infer in
the phylogenetic trees (see Materials and methods). Phyloge-
netic reconstructions were performed for each patient (Figs.
2A–D). Envelopes from CD4+ T cells, plasma, and monocytes
grouped into sub-clusters within some patients, statistically
supported by bootstrapped replicates. Sequences from resting
CD4+ T cells appeared close to the hypothetical root of the
inferred trees, supporting the capacity of T lymphocytes to
harbor HIV proviral DNA throughout the course of the
infection (i.e. archival reservoir). Analysis of sequence-
inferred phylogenetic reconstructions suggested that resting
CD4+ T cells may be the origin of viral forms in the plasma
and monocytes of each patient. An exception for this, Patient
TI-2, presented an almost indistinguishable pattern of evolu-
tion, most likely because of higher and presumably noisy viral
loads.
Nucleotide distance analyses
Since HIV-1 is characterized by a constant sequence
variation, leading to the emergence of distinct viral quasis-
pecies within patients (Kuiken et al., 1993; Lorenzo et al.,
2004b; Malim and Emerman, 2001; Nowak et al., 1991),
intrasample and intersample nucleotide sequence variability
was determined for each patient, based on calculated pairwise
distance matrixes. Little genetic variability (b0.2%) (indica-
tive of homogeneous infection) was observed in proviral HIV
env from monocytes of all patients (Fig. 3). Viral forms in
monocytes shared closer relationship to plasma than to T-
lymphocytes. Molecular clone sequences in plasma showed
little variability in all analyzed patients, with an overall range
of 0–2.1%, except for Patient TI-1 time 4, in whom the viral
forms in plasma ranged from 0.2% to 5.5% distant after an
episode of complete suppression of HIV viral loads (i.e.
rebounding viremia). Finally, clone sequences of CD4+ T
cells were highly variable in all patients, with overall ranges
of 0.2–12% nucleotide distance, which is indicative ofFig. 2. Phylogenetic reconstruction of HIV-1 gp120 envC2-V4 nucleotide sequenc
HF-2. Samples are depicted as follows: closed circles, monocytes; open circles,
likelihood method. Numbers at the branch nodes indicate bootstrap values (1000 re
hypothetical ancestors and used as outgroups (GenBank accession numbers, U0
bottom, indicating the number of substitutions per site. Graphical output was c
nucleotide sequences in Patient TI-1 during antiretroviral treatment interruption. A
following a time point of complete viral suppression (Time 3, not shown because
monocytes; open circles, plasma; open triangles, T cells; gray diamonds, hypothe
replicates). Distance bar is shown at the bottom, indicating the number of substitu
sequences in Patient TI-2 during antiretroviral treatment interruption. Samples ar
triangles, T cells; gray diamonds, hypothetical ancestors. Numbers at the branch n
bottom, indicating the number of substitutions per site.heterogeneous infection. This observation is consistent with
resting CD4+ T cells as archival reservoirs.
Analyses of N-linked glycosylation sites in HIV-1 envelope
The HIV envelope is one of the most glycosylated proteins
and its ability to shift glycosylation patterns provides a
mechanism to evade neutralizing antibodies (Frost et al.,
2005; Wei et al., 2003). N-linked glycosylation patterns (i.e.
additions of saccharides to the amide nitrogen of asparagine
(N) side chains) can be predicted based on inferred protein
sequences to infer viral evolution designed to escape HIV-
specific selective pressures. Patterns of envelope glycosyla-
tions were used to reconstruct infection profiles of the
analyzed cellular populations (Figs. 4A–D). Within each
patient, clone sequences of monocytes showed identical N-
linked glycosylation sites, suggesting an infection with
homogeneous viral population surviving similar selective
pressures. Monocytes and plasma of patients with lower
CD4+ T cell counts showed identical N-glycosylation
patterns, while shifted sites for N-linked glycosylations were
found in patients with higher lymphocyte counts. These
findings indicate that, although these viruses might originate
from similar sources, the effective pressures exerted by
competent immune systems shape each glycan shield rapidly
and accordingly. The shifts in patterns of glycosylations in the
envelope gene associated with the CD4+ T cell count status of
the patient, support our previous studies of viral isolates in
plasma of patients pre and post HAART (Lorenzo et al.,
2004a). Glycosylation models for T lymphocytes were highly
variable, suggesting that virions infecting these cells shifted in
different ways in order to escape multiple and diverse
immune pressures. This observation, as supported by analyses
of nucleotide distances of clone sequences, is also consistent
with the archival reservoir feature of T cells.
Within each analyzed patient, HIV envelope in plasma
showed highly conserved glycosylation patterns, suggesting
that these isolates are surviving under similar selective
pressures, presumably of immune sources. This observation in
plasma of HF patients may be ascribed to the dominance of a
resistant virus. The emergence of a highly variable viral
population in plasma of Patient TI-1 time 4 was also shown by
frequent shifts in N-glycosylations (Fig. 4C). These findings
pinpoint to multiple sources of plasma viremia during
antiretroviral treatment interruption. In contrast, the absolutees in HAART-failing patients with infected blood monocytes: (A) HF-1; (B)
plasma; open triangles, T cells. Each tree was generated by the maximum-
plicates). Sequences of two Puerto Rican HIV-1 env isolates were included as
4926–U04929) and shown as gray diamonds. Distance bar is shown at the
reated using MEGA2. (C) Phylogenetic reconstruction of HIV-1 envC2-V4
nalyses of 3 time points are shown. Time 4 shows the rebounding viremia
of unavailability of samples). Samples are depicted as follows: closed circles,
tical ancestors. Numbers at the branch nodes indicate bootstrap values (1000
tions per site. (D) Phylogenetic reconstruction of HIV-1 envC2-V4 nucleotide
e depicted as follows: closed circles, monocytes; open circles, plasma; open
odes indicate bootstrap values (1000 replicates). Distance bar is shown at the
Fig. 3. Intrasample variability of HIV-1 envC2-V4 in patients with infected monocytes. Deduced protein envelope sequences were aligned BioEdit. Genetic
distance matrix was calculated by pairwise comparisons of clone sequences of each specimen within each patient using MEGA2. The average of these distances
are plotted for each patient and expressed in percentages. Data are depicted as following: black bars, monocytes; dark gray, T cells; light gray, plasma. Error bars
are shown for each bar.
40 S. Almodóvar et al. / Virology 369 (2007) 35–46preservation of glycosylation sites in TI-2 obscures the
inferences about the origins of plasma viremia (Fig. 4D). In
this patient, the viral loads of N100,000 copies/ml may be
representing the predominant viral population that is able to
enter and replenish reservoirs in the absence of suppressive
HAART.
PCR analyses in MDM
Proposed mechanisms of HIV infection in macrophages
include the integration of HIV DNA into host cell genome after
differentiation and/or the infection through cell–cell contact
both within tissues and in the periphery (Orenstein et al., 1988;
Tuttle et al., 1998). In order to test whether HIV-1 DNA can be
detected in monocytes/macrophages after differentiation, pri-
mary monocytes from 4 chronically HIV-infected patients under
suppressive HAART were stimulated with either phorbol
esthers or macrophage–colony-stimulating factors in vitro to
generate monocyte-derived macrophages (MDM). PCR ana-
lyses were performed in MDM, with primers spanning the HIV
genes env, nef and tat. However, HIV proviral DNA did not
detect these target genes. These data suggest that MDM do not
harbor HIV proviral DNAwhen derived from patients receiving
suppressive HAART.
Discussion
Existing evidence proposes that monocytes are active HIV-
1 reservoirs/carriers, although there are data suggesting that
tissue macrophages but not monocytes may have significant
roles in HIV infection. This evidence in the research ofmonocyte virology supports the view that monocytes and
macrophages are indeed two separate cell populations, with
different patterns of cell surface receptors (including CD4,
CCR5 and phagocytic receptors), production of cytokines and
chemokines, and susceptibility to HIV infection. Furthermore,
the extent to which macrophage precursors are infected in vivo
still remains poorly understood. Crucial considerations in the
study of the role of monocytes in HIV infection include the
use of highly pure monocyte preparations and that monocyte
activation and differentiation are affected by isolation and
culture conditions. Numerous studies report the use of freshly
isolated blood monocytes to generate macrophages in vitro
and extrapolate results to tissue macrophages, given the
invasive nature of techniques to reach macrophages in human
subjects and the prohibitive costs of non-human primate
models. The isolation of monocytes by adherence in vitro is
known to promote transient monocyte activation (Haskill et
al., 1988). This practice may allow for the infection of
susceptible cells by residual PBMC virus and may produce
false positives.
Accepting the premise that tissue macrophages can be found
invariably infected with HIV along with its clinical repercus-
sions, we wanted to revisit the issue of whether blood
monocytes are infected in vivo and their role in HIV infection
in the presence or absence of suppressive HAART. We found
that peripheral blood monocytes do not seem to be latent
sources/carriers of HIV in the presence of suppressive
HAART. Our findings are based on freshly isolated blood
monocytes from patients with/without HAART, with no in
vitro manipulations for the isolation of monocytes. Signifi-
cantly, when considering the purity of our monocyte
41S. Almodóvar et al. / Virology 369 (2007) 35–46enrichments (95–99%), any low-level contamination would
become manifest by the exquisite sensitivity of PCR
procedures. Therefore, the non-detection of HIV by PCR in
the monocytes of patients receiving HAART supports the
notion that peripheral blood monocytes do not seem to be
latent sources/carriers of HIV in the presence of suppressive
HAART. Regarding the fact that HIV-1 envelope deletions
have been reported in long term HIV-infected patients (Saurya
et al., 2003), such a likelihood is less probable in our study
subjects given the unsuccessful amplification of other viral
genes (i.e., nef and tat) in monocytes.Fig. 4. Graphs of the N-linked glycosylation sites in HIV-1 C2-V4 envelope region o
Deduced protein sequence alignments derived from each patient were used to predic
database, http://hiv-web.lanl.gov. In each graph, the exact position of a potential N-lin
sites is given by the y-axis. The number of input sequences for each graph is shown (N
of Patient TI-1 during antiretroviral treatment interruption. Analyses for 3 time poin
complete viral suppression (Time 3, not shown because of unavailability of samples)
of Patient TI-2 during antiretroviral treatment interruption. Only the analyses for
monocytes after HAART resumption.In our study, MDM in vitro from primary monocytes of 4
HIV-infected patients were used as mirrors of tissue macro-
phages to determine whether the infection occurs immediately
after differentiation. Again, the non-detection of HIV in
monocyte/macrophages after differentiation in vitro suggests
the HAART-induced refractoriness of monocytes to HIV
infection in patients under suppressive therapy. These findings
confirm and extend results from recent studies. Monocytes are
more likely to be stimulated by the LPS produced by bacterial
translocation from the gut to systemic blood in patients with
chronic HIV infection and AIDS (Brenchley, 2006). Sincef patients failing HAART and with infected monocytes, HF-1 (A) and HF-2 (B).
t glycosylation sites using N-glycosite tool from the Los Alamos HIV Sequence
ked glycosylation site is given by the x-axis; the fraction of clones sharing these
). (C) Graphs of the N-linked glycosylation sites in HIV-1 C2-V4 enveloperegion
ts are shown. Time 4 shows the rebounding viremia following a time point of
. (D) Graphs of the N-linked glycosylation sites in HIV-1 C2-V4 enveloperegion
time point during drug holidays are shown, since HIV-1 was not detected in
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Fig. 4 (continued).
43S. Almodóvar et al. / Virology 369 (2007) 35–46cellular activation is usually accompanied by viral production,
evidence of active infection in monocytes is expected.
However, low levels viral transcription was found in monocytes
when compared to T lymphocytes after fractionation of PBMC
from HIV+ patients (Fischer M, et al., poster 217, CROI 2007 –
Los Angeles, CA). Nevertheless, the present study could be
hampered by the isolation and differentiation of only CD14+
monocytes, given that the CD16+ monocyte subset has
particular susceptibility to HIV and is increased in the blood
of HIV+ individuals (Ancuta et al., 2006b,a) (Tippett E, et al.,
poster 276, CROI 2007 – Los Angeles, CA). Another important
consideration in this study is PCR resampling, since most of our
analyses were performed after single PCR events. Taq
polymerase-introduced base substitution errors range in the
orders of 10−5 to 10−6 per cycle (Eckert and Kunkel, 1990).
Nonetheless, the high genetic variability found in most of theclone sequences clearly outweighs the standard error rates of the
Taq polymerase and is indicative of the viral population
diversity.
The finding of monocytes infected with HIV only in the
absence of suppressive HAART (during either HAART failure
or treatment interruption), allows us to suggest that the HIV
infection of monocytes is directly related to the success of
HAART (pb0.001). Analyses of envelope evolution in
monocytes, by phylogeny, nucleotide distances and N-linked
glycosylations, allowed us to identify a closer relationship
between HIV in monocytes and plasma that suggests a
monocytic “sponge-like behavior”. This finding was high-
lighted in the scenario of rebounding viremia in Patient TI-1
time 4 (75 HIV-1 RNA copies/ml). In this case, under the
limited but diverse viral expression, monocytes harbored
multiple viral forms related to both plasma and resting T cells
(a possible source). Extended analyses of our data may
provide information about viral rebounding processes during
treatment interruption and HAART failure. Analyses of
phylogenetic reconstructions, nucleotide distances and glyco-
sylation are consistent with the theory that T cells act as latent
reservoirs harboring highly diverse and archival viral forms.
Conversely, the same analyses suggested that plasma isolates
represent the viruses expressed in the current settings, i.e.,
“contemporary forms”. In agreement with Siliciano (2005),
resting CD4+ T cells could be the source of active re-
infections, and can cause viral rebound if antiretroviral
therapy is stopped or compromised with viral resistance.
Taken together, these data strongly suggest that monocyte
restrictions to HIV-infection in vivo are mediated also by the
efficacy of HAART. Such likelihood minimizes the role of
monocytes as Trojan horses of HIV and their carrying
capacity of infectious virus into tissues under HAART
suppression. Despite the unquestionable increased suscept-
ibility of either dendritic cells or macrophages to HIV, the
source of this infection is still unknown. Extensive evidence
is available for the viral production of T cells after activation.
Therefore, T cells could amplify HIV upon activation in
tissues and further infect the newly permissive and susceptible
macrophages/dendritic cells within tissues. These new infected
cells might then contribute to the progression of viral
pathogenesis following a T-cell-derived infection. Based on
our results, these circumstances most likely occur in the scenario
of suppressive HAART.
In conclusion, this research study points back to pioneering
studies which suggested that HIV infection was predomi-
nantly a T-cell infection. Nonetheless, HIV studies of
monocytes/macrophages will continue to be relevant, since
the clinical and pathogenic significance of studies establishing
that the majority of monocytes are not infected in patients
with HIV have not been fully described. Many questions still
need answers: What are the mechanisms underlying the
effects of HAART to protect monocytes from infection? What
is the fate of HIV-infected monocytes under sub-optimal
HAART? How might monocyte cytokine dysregulation in
patients with HAART determine increased pathogenesis
(Almeida et al., 2007)?
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non-permissive to HIV infection allows us to support the
minimal role of monocytes as Trojan horses that reseed several
anatomical locations thorough the infection, especially during
suppressive HAART. This likelihood suggests that fully mature
macrophages may be infected by virus already residing in
tissues. Perhaps the lack of infection in circulating monocytes
and the cyclic infection of tissue macrophages with residing
virus is the key to the formation and preservation of anatomical
HIV compartments throughout the asymptomatic HIV disease.
Our findings and discussion present potential clinical issues that
should not be disregarded. We are not minimizing the
importance of macrophages in HIV infection. However, we are
questioning the importance of their precursor cell to be infected
and carry the virus. We believe that the importance of the
monocyte in the clinical translational setting warrants further
attention, especially in the face of suppressive HAART therapy.
Materials and methods
Study subjects
A total of 19 HIV-infected individuals were recruited from
three HIV clinics in Puerto Rico according to protocols
approved by the Institutional Review Board of the Ponce
School of Medicine and under HIPAA regulations. Plasma HIV-
1 viral load was determined by standard (detection limit,
400 copies/ml) and ultrasensitive (detection limit, 50 copies/ml)
Amplicor HIV-1 Monitor test (Roche Molecular Systems, Inc.,
Branchburg, NJ). CD4+ T cells were quantified by flow
cytometry analyses using FACSCalibur (BD Biosciences, San
Jose, CA). The presence of relevant resistance-conferring
mutations in patients in HAART failure or undergoing treatment
interruption was determined using the TRUGENE HIV-1
Genotyping test (Bayer HealthCare). The resistance pattern
was generated using GuideLines 9.0. All the clinical informa-
tion was determined by the Ponce School of Medicine AIDS
Research Program-Reference Laboratory.
Cell isolation
Peripheral bloodmononuclear cells (PBMC)were isolated by
density gradient centrifugation using HISTOPAQUE®-1077
(Sigma Aldrich). CD14Microbeads (Miltenyi Biotec) were used
for the positive selection of blood monocytes. The negative
selection approach was used for the isolation of resting CD4+ T
cells, using the CD4+ T Cell Isolation Kit II (Miltenyi Biotec),
which includes a cocktail of CD8, CD14, CD16, CD19, CD56,
CD36, CD123, and CD235a antibodies for the depletion of
CD8+ T cells, B cells, natural killer (NK) cells, monocytes,
dendritic cells, granulocytes, platelets and erythrocytes. Result-
ing cellular suspensions were incubated with CD25 Microbeads
(Miltenyi Biotec) to isolate the resting subset of CD4+ T cells.
The purity of isolated cells was analyzed by flow cytometry
using a FACSAria (BD Biosciences) after the immunofluor-
escent staining of samples with monoclonal antibodies to the
following cell surface molecules: CD3− PerCP, CD4− FITC,CD25− PE (for the assessment of resting CD4+ T cells (CD3+,
CD4+, CD25−), and CD14− FITC (for CD14+ monocytes),
please refer to Supplementary material).
Differentiation of blood monocytes
Freshly isolated CD14+ monocytes were incubated in
supplemented media (Graziani-Bowering and Filion, 2000;
Keisari, 2005) with either 50 ng/ml macrophage–colony-
stimulating factor (Research Diagnostics) or 100 ng/ml of
phorbol myristate acetate (Sigma) for 48 h. Adherent cells were
incubated for 3–8 days, changing the media every 48 h. The
adhesion to plastic and changes in morphology were used as
criteria to consider monocytes in culture as monocyte-derived
macrophages (MDM).
Amplification of HIV-1 gene regions
Genomic DNA was extracted from all isolated cells (1–
5 million) by using the QIAamp DNA Blood Mini Kit
(QIAGEN). The HotStarTaq DNA Polymerase (QIAGEN) was
used for amplifications of HIV-1 env, using 30–100 ng DNA per
reaction as template. The amplification of C2-V4 env was
performed by using PCR conditions as previously described
(Lorenzo et al., 2004a). Amplification primers for HIV-1 nef and
tat confirmatory genes are detailed in Table S1 (Supplementary
material). The human housekeeping gene β-actin was amplified
and used as an internal positive control (Nagai et al., 2001). PCR
products were analyzed by electrophoresis in 1% TBE agarose
gels stained with ethidium bromide and visualized with UV light.
Sequencing of HIV-1 C2-V4 envelope
PCR products were ligated into vector pCR 2.1 (Invitrogen,
Carlsbad, CA) and cloned in Escherichia coli by standard
procedures. Plasmid DNAwas purified by using QIAprep Spin
Miniprep columns (QIAGEN Inc.). Molecular clones were
sequenced with M13 primers using an Applied Biosystems
3100 Genetic Analyzer by Big-Dye terminator chemistry.
Sequence analyses
Sequences were aligned at the nucleotide level using the
program Clustal X (Thompson et al., 1997), and then protein
alignments were derived from the nucleotide alignments. For
each data set the best fit model of sequence evolution was
determined using the AIC criterion in the programModeltest 3.7
(Posada and Crandall, 1998). Phylogenetic trees were inferred
using the program PAUP⁎ (Swofford, 2002) with NJ and ML
distances based on the models determined by Modeltest.
Bootstrap trees are based on 1000 replicates. The outgroups
for the analyses include envelope sequences from 2 unrelated
individuals sampled in Puerto Rico in 1994 and therefore, used
as hypothetical ancestors (GenBank accession numbers,
U04928–U04929). Potential N-linked glycosylation sites were
determined by using the N-glycosite tool of Los Alamos HIV
Sequence database, http://hiv-web.lanl.gov (Zhang et al., 2004).
45S. Almodóvar et al. / Virology 369 (2007) 35–46Statistical analyses
Determination of correlations between the presence of
infected monocytes, CD4 T cell counts and viral loads were
determined by using the Mann–Whitney's test. Statistical
association between the presence of infected monocytes and
HAART was determined by Chi-square tests. All the statistical
tests used for data analysis are included in the SPSS Version
12.0 software package (SPSS, Inc. Chicago, IL).
Accession numbers
Sequences reported in this manuscript were given GenBank
accession numbers DQ387660–DQ387853.
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